A quantitative study of epidermal Langerhans cells in cutaneous leishmaniasis caused by Leishmania tropica

International Journal of Dermatology

Volumn 43, Issue 11, 2004, Pages 819-823

  Meymandi, Simin ^a,b,c,d   Dabiri, Shahriar ^a,b,c   Dabiri, Darya ^a,b,c   Crowford, Richard I ^a,b,c,d   Kharazmi, Arsalan ^a,b,c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Mental Health Services CPH   (Denmark)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; PARAFFIN; T6 ANTIGEN;

ACUTE DISEASE; ARTICLE; CELL COUNT; CELL POPULATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; EPIDERMIS CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LEISHMANIA TROPICA; PAPULE; QUANTITATIVE ANALYSIS; SCAR; SKIN LEISHMANIASIS;

ANIMALS; CELL COUNT; HUMANS; LANGERHANS CELLS; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; RETROSPECTIVE STUDIES;

EID: 8844232700     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02359.x     Document Type: Article

References (38)

1. Herwadlt B. Leishmaniasis seminar. Lancet 1999; 354 1191-1199.
2. Salman SM, Rubeiz NG, Kibbi AG. Cutaneous leishmaniasis: clinical features and diagnosis. Clin Dermatol 1999; 17: 291-296.
3. WHO. Control of Leishmaniasis. Technical Report Series. Geneva: World Health Organization, 1990: 793.
4. Gilliam AC, Kremer IB, Yoshida Y, et al. The human hair follicle: a reservoir of CD40+ B7-deficient Langerhans cells that repopulate epidermis after UVB exposure. J Invest Dermatol 1998; 110: 422-427.
5. Rowden G. The Langerhans cell. Crit Rev Immunol 1981; 3: 95-180.
6. Schuler G. Epidermal Langerhans Cells. Boca Raton: CRC Press, 1991.
7. Horton JJ, Allen MH, MacDonald DM. An assessment of Langerhans cell quantification in tissue sections. J Am Acad Dermatol 1984; 11: 591-593.
8. Valladeau J, Ravel O, Dezutter-Dambuyant C, et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000, 12, 71-81.
9. Ashworth J, Booker J, Breathnach SM. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br J Dermatol 1988; 118: 457-469.
10. Breathnach SM, Katz SI. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF). J Invest Dermatol 1985; 85 553-558.
11. Aberer W, Schuler G, Stingl G, et al. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981; 76: 202-210.
12. Ashworth J, Kahan MC, Breathnach SM. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CD1a+ Langerhans cells exhibit normal alloantigen presenting function. Br J Dermatol 1989; 120: 329-339.
13. Dam TN, Moller B, Hindkjaer J, et al. The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J Invest Dermatol Symp Proc 1996; 1: 72-77.
14. Shioharat T, Mariya Tanka K, et al. Immunopathologic study of lichenoid skin disease: correlation between HLA-DR positive keratinocytes or Langerhans cells and epidermotropic T-cells. J Am Acad Dermatol 1988; 18: 67-74.
15. Gaafar A, Veress B, Permin H, et al. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol 1999; 91: 314-320.
16. Giannini MS. Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation. Infect Immun 1986; 51: 838-843.
17. Isaza DM, Restrepo M, Restrepo R, et al. Imunocytochemical and histopathologic characterization of lesions from patients with localized cutaneous leishmaniasis caused by Leishmania panamensis. Am J Trop Med Hyg 1996; 55: 365-369.
18. Kaplan G, Nusrat A, Witmer MD, et al. Distribution and turnover of Langerhans cells during delayed immune responses in human skin. J Exp Med 1987; 165: 763-776.
19. Moll H. Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response. Adv Exp Med Biol 1993a; 329: 587-592.
20. Moll H, Fuchs H, Blank C, et al. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 1993; 23: 1595-1601.
21. Moll H, Flohe S, Rollinghoff M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol 1995; 25: 693-699.
22. Moll H, Flohe S. Dendritic cells induce immunity to cutaneous leishmaniasis in mice. Adv Exp Med Biol 1997; 417: 541-545.
23. Solbach W, Laskay T. The host response to Leishmania infection. Adv Immunol 2000; 74: 275-317.
24. Sharifi I, Fekri AR, Aflatonian MR, et al. Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-95. Bull World Health Organ 1998; 76: 289-293.
25. Kernacs L, Tiszlavics L, Kernacs T, et al. Immunohistochemical detection of CD1a antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody O10. J Pathol 1993; 171: 99-104.
26. Boumsell L. Cluster Report: CD1a. Oxford: Oxford University Press, 1989; 251-254.
27. von Stebut E, Belkaid Y, Jakob T, et al. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 1998; 188: 1547-1552.
28. Azadeh B, Abdulla F. Transepithelial elimination in cutaneous leishamaniasis. Acta Dermatol Venereol (Stockh) 1994; 75: 159.
29. Kimber I, Cumberbatch M, Dearman RJ, et al. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 2000; 142: 401-412.
30. Kimber I, Cumberbatch M, Dearman RJ, et al. Mobilization of epidermal Langerhans cells - reply from the authors. Br J Dermatol 2000; 143: 894.
31. Narayanan RB, Girdhar A, Girdhar BK. CD1a-positive epidermal Langerhans cells in regressed tuberculoid and lepromatous leprosy lesions. Int Arch Allergy Appl Immunol 1990; 92: 94-96.
32. Meunier L. Ultraviolet light and dendritic cells. Eur J Dermatol 1999; 9: 269-275.
33. Mork NJ, Borufsen H, Braathen LR: UVC irradiation of human epidermal Langerhans cells decreases the alloactivating and antigen presenting capacity. Clin Exp Dermatol 1988; 13: 371-375.
34. Nakagawa S, Koomen CW, Bos JD, et al. Differential modulation of human epidermal Langerhans cell maturation by ultraviolet B radiation. J Immunol 1999; 163: 5192-5200.
35. Ullrich SE. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. J Immunol 1994; 152: 3410-3416.
36. Gaafar A, el Kadaro AY, Theander TG, et al. The pathology of cutaneous leishmaniasis due to Leishmania major in Sudan. Am J Trop Med Hyg 1995; 52: 438-442.
37. Mehregan DR, Mehregan AH, Mehregan DA. Histologic diagnosis of cutaneous leishmaniasis. Clin Dermatol 1999; 17: 297-304.
38. Azadeh B, Samad A, Ardehali S. Histological spectrum of cutaneous leishmaniasis due to Leishmania tropica. Trans R Soc Trop Med Hyg 1985; 79: 631-636.